To date, liraglutide, semaglutide, albiglutide, and dulaglutide (but not exenatide or lixisenatide) have shown superiority compared to placebo for reduction in a 3P-MACE endpoint (62)
Who these treatments are for GLP-1 medications are approved for adults with: Obesity (BMI of 30 kg/m or higher) A BMI of 27 kg/m or higher with at least one weight-related condition such as high blood pressure Among individuals with a BMI of 27 kg/m or more, additional benefits have been found
M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F
Mounjaro, which contains tirzepatide, is approved for type 2 diabetes but is commonly used off-label for weight loss
doi: 52
There are side effects to every medication, even approved medications, but when things are being touted as 100 percent safe, or you get all these great results, theres usually something fishy going on. MTII is largely unregulated and lacks standards for purity, sterility and dosing